Cronos Group Inc. (CRON)
Sector: Medicinal Chemicals & Botanical Products
Industry: Drug Manufacturers - Specialty & Generic
Cronos Group Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 3.70 | 3.71 | 3.55 | 3.61 | 1,315,983 |
| Nov 5, 2026 | 3.71 | 3.91 | 3.60 | 3.72 | 3,971,179 |
| Nov 4, 2026 | 3.45 | 3.57 | 3.44 | 3.51 | 2,118,772 |
| Nov 3, 2026 | 3.36 | 3.46 | 3.34 | 3.38 | 1,124,880 |
| Nov 2, 2026 | 3.32 | 3.40 | 3.31 | 3.33 | 1,010,108 |
| Oct 30, 2026 | 3.35 | 3.36 | 3.27 | 3.30 | 1,091,082 |
| Oct 29, 2026 | 3.35 | 3.39 | 3.32 | 3.36 | 666,416 |
| Oct 28, 2026 | 3.38 | 3.38 | 3.32 | 3.35 | 536,170 |
| Oct 27, 2026 | 3.30 | 3.40 | 3.30 | 3.38 | 751,460 |
| Oct 26, 2026 | 3.37 | 3.41 | 3.29 | 3.31 | 827,875 |
| Oct 23, 2026 | 3.42 | 3.43 | 3.30 | 3.35 | 816,806 |
| Oct 22, 2026 | 3.39 | 3.46 | 3.37 | 3.44 | 995,558 |
| Oct 21, 2026 | 3.30 | 3.44 | 3.27 | 3.39 | 1,146,705 |
| Oct 20, 2026 | 3.26 | 3.31 | 3.25 | 3.28 | 885,500 |
| Oct 19, 2026 | 3.21 | 3.27 | 3.20 | 3.25 | 788,362 |
| Oct 16, 2026 | 3.23 | 3.35 | 3.21 | 3.21 | 865,945 |
| Oct 15, 2026 | 3.17 | 3.26 | 3.17 | 3.20 | 807,893 |
| Oct 14, 2026 | 3.17 | 3.22 | 3.15 | 3.16 | 955,240 |
| Oct 13, 2026 | 3.21 | 3.25 | 3.18 | 3.20 | 522,867 |
| Oct 12, 2026 | 3.22 | 3.23 | 3.20 | 3.21 | 687,154 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Martens Christopher | General Manager | Grant/Award | 46.9K | -- | Oct 16, 2026 |
 RUDYK JAMES DANIEL | Director | Grant/Award | 48.9K | -- | Aug 6, 2026 |
 Garnick Murray R | Director | Grant/Award | 48.9K | -- | Aug 6, 2026 |
 ADLER JASON MARC | Director | Grant/Award | 48.9K | -- | Aug 6, 2026 |
 Kenost Jared Matthew | See Remarks | Option Exercise | 9.4K | -- | May 12, 2026 |
| Kenost Jared Matthew | See Remarks | Automatic Sell | 3.7K | $10.2K | May 12, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
Altria Group, Inc. 2 · may incl. warrants· stale · filed Apr 2024 | 156.6M | 42.7% | 13D |
 GORENSTEIN MICHAEL RYAN See remarks below, Director | 13.2M | 3.6% | FORM 4 |
D. E. Shaw & Co., Inc. | 8.8M | 2.4% | 13F |
Chescapmanager LLC | 7.9M | 2.2% | 13F |
Tidal Investments LLC | 3.8M | 1.0% | 13F |
DIMENSIONAL FUND ADVISORS LP | 3.2M | 0.9% | 13F |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2.0M | 0.5% | 13F |
MACKENZIE FINANCIAL CORP | 1.9M | 0.5% | 13F |
RENAISSANCE TECHNOLOGIES LLC | 1.7M | 0.5% | 13F |
CIBC WORLD MARKET INC. | 1.4M | 0.4% | 13F |
Insiders
- Martens ChristopherGeneral Manager
- RUDYK JAMES DANIELDirector
- Garnick Murray RDirector
- ADLER JASON MARCDirector
- Kenost Jared MatthewSee Remarks
- Doucet Terrence Gregory JosephSee Remarks
- Wagner AdamSee remarks
- Buggy ShannonSee Remarks
- Weigensberg AryeSee Remarks
- Shlimak AnnaSee Remarks
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption.
Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand.
Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
based on 366.47M shares outstanding
CA30d Avg
1.09M
60d Avg
983.86K
90d Avg
1.09M